Latest News

Election Success for Jenner Investigator

Election Success for Jenner Investigator

Posted 08/09/2014

  Helen McShane, BSc MBBS PhD London, Faculty of Clinical Medicine, has been voted onto Oxford University Council. From September, she will represent two Divisions: Medical Sciences (MedSci) and Mathematical, Physical and Life Sciences (MPLS). This is a prestigious post which will put one of ...

Malaria vaccine offers new mode of protection against disease

Malaria vaccine offers new mode of protection against disease

Posted 14/10/2014

Press release: A novel malaria vaccine developed at Oxford University has shown promising results in the first clinical trial to test whether it can protect people against the mosquito-borne disease.

'Cautious optimism' on HIV

'Cautious optimism' on HIV

Posted 28/09/2014

BBC Radio 4: HIV has been one of modern medicine's most implacable foes. Thirty one years since AIDS was first observed in the west with 30m deaths worldwide since, it has been tamed but not beaten.

Malaria vaccine for infants disappoints in study

Malaria vaccine for infants disappoints in study

Posted 28/09/2014

CBS: An experimental malaria vaccine once thought promising is turning out to be a disappointment, with a new study showing it is only about 30 percent effective at protecting infants from the killer disease.

Interactive video: Synthetic viruses

Interactive video: Synthetic viruses

Posted 13/10/2014

BBC: Medical correspondent Fergus Walsh explains how British scientists have used a new technique to develop a synthetic virus which heralds a major development in vaccines.

Synchrotron particle accelerator yields 'safer' vaccines

Synchrotron particle accelerator yields 'safer' vaccines

Posted 14/10/2014

BBC: British scientists have developed a new, safer, method of creating vaccines using a particle accelerator, according to research published in the PLOS Pathogens journal.

First results from an Oxford University trial of an Ebola vaccine

First results from an Oxford University trial of an Ebola vaccine

Posted 13/01/2015

A trial of a GSK/NIH candidate Ebola vaccine at Oxford University suggests the vaccine has an acceptable safety profile and is able to generate an immune response.

If you have news or events that you would like to be added to this website, please email us details. If possible, please include a picture and links to further information.